JAMA Intern Med:孕期新冠肺炎感染与围产期不良事件风险

2022-03-22 网络 网络

SARS-CoV-2感染导致孕产妇围产期严重疾病、早产以及血栓风险增加,支持孕期及备孕人群积极接种新冠肺炎疫苗。

自Covid-19疫情以来,怀孕期间SARS-CoV-2感染及其与围产期并发症的潜在关联、如何告知孕妇可能的感染风险以及疫苗接种,这些问题始终难以达成共识近日研究人员开展大规模队列研究,考察了孕产妇SARS-CoV-2感染相关的围产期并发症风险及预后。

研究人员收集北加州43886 名孕妇的孕期电子病例数据,时间范围为2020年3月1日至2021年3月16日,包含孕产妇从受孕前30天到分娩后7天的SARS-CoV-2感染情况。研究的主要终点为围产期21种严重疾病(如急性心肌梗死、急性肾功能衰竭、急性呼吸窘迫综合征和脓毒症)、早产、妊娠高血压、妊娠糖尿病、静脉血栓(VTE)、死产、剖宫产、新生儿出生体重和呼吸异常等。
参与研究孕产妇平均年龄30.7岁,其中新冠肺炎感染者1332人(3.0%),感染人群的年龄较低、西班牙裔以及患有肥胖或高血压的比例较高。在调整了人口统计学特征、共病和吸烟状况后,新冠肺炎感染孕产妇的严重围产期疾病(HR=2.45)、早产(<37周;HR=2.08)、,孕期糖尿病风险增加(HR=7.03)、VTE(HR=3.08)风险显著增加,特别是早期早产风险高于中后期风险(HR早期 vs 中期 vs 后期:2.52 vs 2.18 vs 1.95)。新冠肺炎阳性孕产妇中,76人住院(5.7%),亚裔(HR=2.33)及黑人(HR=3.14)阳性孕妇的住院率较高。

SARS-CoV-2感染与孕产妇不良结局风险

研究认为,SARS-CoV-2感染导致孕产妇围产期严重疾病、早产以及血栓风险增加,支持孕期及备孕人群积极接种新冠肺炎疫苗。
原始出处:
Assiamira Ferrara et al. Perinatal Complications in Individuals in California With or Without SARS-CoV-2 Infection During Pregnancy. JAMA Intern Med. March 21, 2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1808787, encodeId=8bb61808e872a, content=<a href='/topic/show?id=6d52821e35a' target=_blank style='color:#2F92EE;'>#肺炎感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82173, encryptionId=6d52821e35a, topicName=肺炎感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Wed Jan 25 05:25:52 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007416, encodeId=6011200e416f0, content=<a href='/topic/show?id=609c2048199' target=_blank style='color:#2F92EE;'>#不良事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20481, encryptionId=609c2048199, topicName=不良事件风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66962500501, createdName=yige2004, createdTime=Fri Sep 02 14:25:52 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611502, encodeId=65dd16115028c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 24 07:25:52 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205024, encodeId=301412050245d, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>很有独特见解, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b916565509, createdName=ms6000000823723189, createdTime=Tue Mar 22 20:41:48 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204977, encodeId=477e12049e709, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Tue Mar 22 16:41:04 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2023-01-25 zhwj
  2. [GetPortalCommentsPageByObjectIdResponse(id=1808787, encodeId=8bb61808e872a, content=<a href='/topic/show?id=6d52821e35a' target=_blank style='color:#2F92EE;'>#肺炎感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82173, encryptionId=6d52821e35a, topicName=肺炎感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Wed Jan 25 05:25:52 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007416, encodeId=6011200e416f0, content=<a href='/topic/show?id=609c2048199' target=_blank style='color:#2F92EE;'>#不良事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20481, encryptionId=609c2048199, topicName=不良事件风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66962500501, createdName=yige2004, createdTime=Fri Sep 02 14:25:52 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611502, encodeId=65dd16115028c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 24 07:25:52 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205024, encodeId=301412050245d, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>很有独特见解, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b916565509, createdName=ms6000000823723189, createdTime=Tue Mar 22 20:41:48 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204977, encodeId=477e12049e709, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Tue Mar 22 16:41:04 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1808787, encodeId=8bb61808e872a, content=<a href='/topic/show?id=6d52821e35a' target=_blank style='color:#2F92EE;'>#肺炎感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82173, encryptionId=6d52821e35a, topicName=肺炎感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Wed Jan 25 05:25:52 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007416, encodeId=6011200e416f0, content=<a href='/topic/show?id=609c2048199' target=_blank style='color:#2F92EE;'>#不良事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20481, encryptionId=609c2048199, topicName=不良事件风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66962500501, createdName=yige2004, createdTime=Fri Sep 02 14:25:52 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611502, encodeId=65dd16115028c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 24 07:25:52 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205024, encodeId=301412050245d, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>很有独特见解, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b916565509, createdName=ms6000000823723189, createdTime=Tue Mar 22 20:41:48 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204977, encodeId=477e12049e709, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Tue Mar 22 16:41:04 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1808787, encodeId=8bb61808e872a, content=<a href='/topic/show?id=6d52821e35a' target=_blank style='color:#2F92EE;'>#肺炎感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82173, encryptionId=6d52821e35a, topicName=肺炎感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Wed Jan 25 05:25:52 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007416, encodeId=6011200e416f0, content=<a href='/topic/show?id=609c2048199' target=_blank style='color:#2F92EE;'>#不良事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20481, encryptionId=609c2048199, topicName=不良事件风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66962500501, createdName=yige2004, createdTime=Fri Sep 02 14:25:52 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611502, encodeId=65dd16115028c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 24 07:25:52 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205024, encodeId=301412050245d, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>很有独特见解, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b916565509, createdName=ms6000000823723189, createdTime=Tue Mar 22 20:41:48 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204977, encodeId=477e12049e709, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Tue Mar 22 16:41:04 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2022-03-22 ms6000000823723189

    #学习#很有独特见解

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1808787, encodeId=8bb61808e872a, content=<a href='/topic/show?id=6d52821e35a' target=_blank style='color:#2F92EE;'>#肺炎感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82173, encryptionId=6d52821e35a, topicName=肺炎感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Wed Jan 25 05:25:52 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007416, encodeId=6011200e416f0, content=<a href='/topic/show?id=609c2048199' target=_blank style='color:#2F92EE;'>#不良事件风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20481, encryptionId=609c2048199, topicName=不良事件风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66962500501, createdName=yige2004, createdTime=Fri Sep 02 14:25:52 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611502, encodeId=65dd16115028c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 24 07:25:52 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205024, encodeId=301412050245d, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>很有独特见解, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b916565509, createdName=ms6000000823723189, createdTime=Tue Mar 22 20:41:48 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204977, encodeId=477e12049e709, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Tue Mar 22 16:41:04 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2022-03-22 MedSciZeng

    谢谢

    0

相关资讯

BMJ:新冠肺炎流行期间,孕妇的健康和围产期结局怎么样?

对covid-19的发病率、危险因素、临床表现和结果进行量化,是在大流行未来趋势不明晰的情况下制定对临床孕产妇护理和管理方案的关键。

哈尔滨市一确诊新冠肺炎产妇产下健康女婴

据中新网报道,哈尔滨市卫生健康委3日发布消息,哈尔滨市一感染新冠肺炎产妇产下一6斤1两的女婴。目前,母女健康。1月30日,哈尔滨市卫健委接到报告,有1例孕38周+3,发热37.3℃,与武汉返哈确诊病例有密切接触的患者,经核酸检测和专家会诊确诊为新型冠状病毒感染病人,需协调下一步的诊疗处置。哈尔滨市卫生健康委抽调多学科专家,组成专家组进行会诊。考虑到妊娠期妇女对病毒性呼吸系统感染的炎症应急反应性明显

BMJ:新冠肺炎母婴垂直传播风险研究

SARS-CoV-2感染产妇其后代SARS-CoV-2的阳性率较低,但现有证据证实了SARS-CoV-2的母婴垂直传播,母亲Covid-19的严重程度与后代的SARS-CoV-2阳性风险有关